Our medical team evaluates your health and prescribes GLP-1 medications such as semaglutide or tirzepatide when appropriate, so you do not need a separate referral
Some people will have horrific side effects that impact their lives and, even if they are not fatal, they will also not end when they stop taking the medication
Novo Nordisk found evidence of compounded drugs with impurities or no semaglutide, according to a news release in May
Conclusion Emerging evidence underscores the cardioprotective effects of GLP-1RAs, which make them potentially useful for different subpopulations of patients with cardiovascular diseases, including those with HFpEF
Benefits Initial pharmacologic treatment for T2DM typically begins with monotherapy using an oral glucose-lowering agent
Semaglutide Approved by the FDA in 2014 for weight management, semaglutide is a glucagon-like Protein-1 receptor (or GLP-1) drug designed to treat type 2 diabetes and obesity